Abstract
Mycobacterium tuberculosis is a notorious pathogen that continues to threaten human health. Rv0164, an antigen of both T- and B cells conserved across mycobacteria, and MSMEG_0129, its close homolog in Mycobacterium smegmatis, are predicted members of the START domain superfamily, but their molecular function is unknown. Here, gene knockout studies demonstrate MSMEG_0129 is essential for bacterial growth, suggesting Rv0164 may be a potential drug target. The MSMEG_0129 crystal structure determined at 1.95 Å reveals a fold similar to that in polyketide aromatase/cyclases ZhuI and TcmN from Streptomyces sp. Structural comparisons and docking simulations, however, infer that MSMEG_0129 and Rv0164 are unlikely to catalyze polyketide aromatization/cyclization, but probably play an irreplaceable role during mycobacterial growth, for example, in lipid transfer during cell envelope synthesis.
| Original language | English |
|---|---|
| Pages (from-to) | 1445-1457 |
| Number of pages | 13 |
| Journal | FEBS Letters |
| Volume | 592 |
| Issue number | 8 |
| DOIs | |
| State | Published - Apr 2018 |
| Externally published | Yes |
Keywords
- MSMEG_0129
- Mycobacterium tuberculosis
- Rv0164
- START domain superfamily
- structure